Trellus Health plc (AIM:TRLS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
0.9500
-0.0490 (-5.16%)
Jun 6, 2025, 4:35 PM GMT+1

Trellus Health Statistics

Total Valuation

Trellus Health has a market cap or net worth of GBP 1.53 million. The enterprise value is -1.94 million.

Market Cap 1.53M
Enterprise Value -1.94M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date Jun 26, 2025
Ex-Dividend Date n/a

Share Statistics

Trellus Health has 161.51 million shares outstanding.

Current Share Class 161.51M
Shares Outstanding 161.51M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 18.18%
Owned by Institutions (%) 72.83%
Float 85.30M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 16.85
PB Ratio 0.16
P/TBV Ratio 0.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.31
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.15

Current Ratio 12.15
Quick Ratio 12.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -49.78% and return on invested capital (ROIC) is -32.09%.

Return on Equity (ROE) -49.78%
Return on Assets (ROA) -30.94%
Return on Invested Capital (ROIC) -32.09%
Return on Capital Employed (ROCE) -68.22%
Revenue Per Employee 4,793
Profits Per Employee -327,159
Employee Count 19
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -31.03% in the last 52 weeks. The beta is 2.25, so Trellus Health's price volatility has been higher than the market average.

Beta (5Y) 2.25
52-Week Price Change -31.03%
50-Day Moving Average 1.76
200-Day Moving Average 1.41
Relative Strength Index (RSI) 8.05
Average Volume (20 Days) 586,581

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Trellus Health had revenue of GBP 91,060 and -6.22 million in losses. Loss per share was -0.04.

Revenue 91,060
Gross Profit 91,060
Operating Income -6.41M
Pretax Income -6.22M
Net Income -6.22M
EBITDA -5.72M
EBIT -6.41M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 3.47 million in cash and n/a in debt, giving a net cash position of 3.47 million or 0.02 per share.

Cash & Cash Equivalents 3.47M
Total Debt n/a
Net Cash 3.47M
Net Cash Per Share 0.02
Equity (Book Value) 9.40M
Book Value Per Share 0.06
Working Capital 3.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -5.85M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -7,041.21%
Pretax Margin -6,826.30%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Trellus Health does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -405.13%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a